Skip to main content
. 2019 Dec 23;3(24):4238–4251. doi: 10.1182/bloodadvances.2019000647

Table 1.

Clinical and biological characteristics of the study population (N = 86)

n (%) or mean [range]
Tumoral involvement (N = 86)
 Skin 73* (84.9)
 Lymph nodes 48 (55.8)
 Spleen 19 (22)
 Liver 15 (17.4)
 Cerebrospinal fluid 4 (4.5)
 Eye 3 (3.5)
Complete blood count (n = 79)
 White blood cells, ×109/L 1 [0.8-53.8]
  Neutrophils 2.7 [0.02-10]
  Eosinophils 0.2 [0-4.1]
  Basophils 0.02 [0-0.2]
  Lymphocytes 2.1 [0.3-9.3]
  Monocytes 0.5 [0-3]
  Myelemia 0.1 [0-1.6]
  Blasts 5.4 [0-45]
 Hemoglobin, g/dL 11.2 [6.5-18.4]
 Platelets, ×109/L 106 [13-302]
Bone marrow aspirates (n = 73), %
 Blasts 64.0 [0-100]
 Neutrophil line 17.0 [0-66]
 Eosinophils line 0.8 [0-21]
 Basophils line 0.1 [0-3]
 Erythroblasts 10.0 [0-50]
 Lymphocytes and plasma cells 8.0 [0-48]
 Monocytes 1.4 [0-9]
Blast morphologies, %
 Vacuoles only 26/21
 Pseudopodia and vacuoles 68/17
 Undifferentiated morphology 65/7
 Lymphoid-like morphology 18/68
 Monocytoid-like morphology 17/6
 Blasts with granulations 17/3
*

Including 40 cases with a single cutaneous lesion.

Percentage of total bone marrow cells.

Number of cases presenting these characteristics/mean proportion of blast cells presenting this morphology.